152. SINTILIMAB PLUS CISPLATIN AND PACLITAXEL INDUCTION TREATMENT FOR BORDERLINE RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A PHASE II CLINICAL TRIAL. - Wu, Jia-Di; Wang, Zhi-Qiang; Zhao, Ze-Rui; Li, Qiao-Qiao; Li, Zhi-Chao; Li, Yu-Hong (Diseases of the Esophagus, 2023)